Fenofibrate 40 mg/ 120 mg (Fenofibrate) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources.
Antara ; Generic Name: fenofibrate · Brand Name: Antara · Drug Class: Fibric Acid Agents, Peroxisome Proliferator Activated Receptor (PPAR) Agonists
Fenoglide ; Generic Name: fenofibrate tablets ; Brand Name: Fenoglide ; Drug Class: Fibric Acid Agents, Peroxisome Proliferator Activated Receptor (PPAR) Agonists
Statin 복용으로 LDL-C 목표치 도달 후에도 TG 200 mg/dL 이상으로 추가적인 TG 관리가 필요한 환자증례54세 여성으로 당뇨병과...
Although fibrates in general (including fenofibrate) are effective at lowering levels of triglycerides, VLDL cholesterol, total cholesterol, and apolipoprotein C-III, they do not appear to reduce the risk of cardiovascular events or cardiovascular/non-cardiovascular mortality, even when used in combination with a statin. You should not take fenofibrate if you have liver disease, gallbladder disease, severe kidney disease, or if you are breast-feeding a baby. Fenofibrate can cause the breakdown o...
Triglide ; Generic Name: fenofibrate ; Brand Name: Triglide ; Drug Class: Fibric Acid Agents, Peroxisome Proliferator Activated Receptor (PPAR) Agonists
Tricor ; Generic Name: fenofibrate · Brand Name: Tricor · Drug Class: Fibric Acid Agents, Peroxisome Proliferator Activated Receptor (PPAR) Agonists
Hypercholesterolemia, Mixed Dyslipidemia: initial 120-160 mg PO qDay Hypertriglyceridemia: 40... dose adjustments may be necessary Fenofibrate increases cholesterol excretion into bile...
Trilipix ; Generic Name: fenofibric acid capsules ; Brand Name: Trilipix ; Drug Class: Fibric Acid Agents, Peroxisome Proliferator Activated Receptor (PPAR) Agonists
Fenofibric acid (active moiety) and fenofibrate are antilipemic agents; fibric acid derivatives. Adjuncts to dietary therapy to decrease elevated serum total and LDL-cholesterol, triglyceride, and apolipoprotein B (apo B) concentrations, and to increase HDL-cholesterol concentrations in the management of primary hypercholesterolemia and mixed dyslipidemia, including heterozygous familial hypercholesterolemia and other causes of hypercholesterolemia. Additive antilipemic effects when used concomi...